Autoantibodies in rheumatoid arthritis and their clinical significance. - Wikidata - awgldk - TriplyDB

Autoantibodies in rheumatoid arthritis and their clinical significance.

Autoantibodies in rheumatoid arthritis and their clinical significance.

http://www.wikidata.org/entity/Q34731269

about

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin The role and clinical implications of G6PI in experimental models of rheumatoid arthritis Direct interaction of immunoglobulins with synovial fibroblasts: a missing link in the pathogenesis of rheumatoid arthritis?Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity The role of the complement and the Fc gamma R system in the pathogenesis of arthritis Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system.Pathophysiological roles for IL-18 in inflammatory arthritis Prostaglandin E2 synthesizing enzymes in rheumatoid arthritis B cells and the effects of B cell depleting therapy on enzyme expression BET proteins are a key component of immunoglobulin gene expression.Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads.The emerging field of osteoimmunology Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening.Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis.Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts.Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.Role of sphingosine kinase and sphingosine-1-phosphate in inflammatory arthritis FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy.Immunodiagnostic significance of anti-RA33 autoantibodies in Saudi patients with rheumatoid arthritis.Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.Chemical biology of protein arginine modifications in epigenetic regulation Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis.Determination of specificity and sensitivity of anti-RA 33 in diagnosis of early rheumatoid arthritis.Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain.Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis.Sphingosine kinase and sphingosine-1-phosphate receptors: novel therapeutic targets of rheumatoid arthritis?Anti-citrullinated protein antibodies: role in pathogenesis of RA and potential as a diagnostic tool.T cell specific Cxcr5 deficiency prevents rheumatoid arthritis.Reliable and cost-effective serodiagnosis of rheumatoid arthritis.Anticyclic citrullinated peptide antibody and rheumatoid factor in south Tunisian patients with rheumatoid arthritis: association with disease activity and severity.Patterns of Care Among Patients Referred to Rheumatologists in Ontario, Canada.Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis.Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.Effects of Vitamin K on Matrix Metalloproteinase-3 and Rheumatoid Factor in Women with Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.Role of B cells in systemic lupus erythematosus and rheumatoid arthritis.Aging, Obesity, and Inflammatory Age-Related Diseases.Biomarkers in connective tissue diseases.Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues.

P2860

Q21195679-549B8345-C571-41A4-80B7-AC4F118D2D85 Q24799403-8CC16719-2280-468D-AF22-DB3BB12C7206 Q24799469-B5CB2CAE-A6D8-483C-9E73-C3276B10BAE3 Q24816615-F1444D55-5B57-4AE7-A6CA-4C054D451D38 Q24817177-0503F5E7-9F28-4B77-87D8-5B129FB6BB46 Q27692640-3A1F22EA-6372-4F39-BFA3-EF170509F366 Q28187644-5C9A1941-595A-44D0-B930-2BE9BAB84065 Q28743224-8135DBD0-C07A-4273-87CB-155B4D86EDF2 Q33811659-8CB4EC13-EB63-4A61-8774-B7105827E3A7 Q34020523-7B8B73D8-AFA2-4807-A801-3000E23D9B83 Q34108110-908F4F6F-2200-4B75-9979-12E43EE461BA Q34312702-48C1073E-EC88-468E-B117-B49DBA478470 Q34367709-388F134F-FC0F-4A7D-9E6B-935AEAFA3715 Q34530440-7D44CB1F-DE31-4FB1-A5CE-D533B0A9F2DF Q34572942-8BC3B89F-BA31-421E-B495-A35287332445 Q34635933-F35A574D-7663-4A2B-A6C7-0BB69F855948 Q34790990-91A2E2A8-535E-4978-85CB-15EF717D0258 Q34878540-C4E01415-36CB-4AF5-8561-B13BC21DE863 Q35106872-7E38794F-D499-4CB4-9F9E-5C3D1A9C7F3B Q35321526-6F262F98-B10E-4863-89BF-9225AD2151AC Q35555021-BD43EE23-0C5F-4DEE-8639-4811AC4B242E Q35722457-94D93C9A-2F20-41BA-A7E0-26A03F7BDA2E Q35808002-A1721595-5732-4734-90B2-9AD92FCD3A9D Q36228311-8EBF7B30-B4E7-4E32-8C77-F482F4C289B8 Q36779918-4AD147F9-DA1F-4772-9C22-7238B0D3E5A3 Q37499536-AAA468C1-28AC-422C-91EC-602828C6D400 Q37898025-4CC35031-F731-48BC-B334-E6DB5A339A58 Q38005190-EDA6A57D-9E08-4EF7-B0BE-E9CB8029428B Q38078245-307E3727-13D4-46D9-8F02-91399CD1B256 Q38615369-88C2D94A-47A2-42B5-9C04-41546AD9235D Q38726475-2B8301E0-51EE-4400-9968-E7D780A794BA Q39042536-2B0E65DD-4ABE-4678-8514-81D94C9AE12B Q39825257-2BCE0C97-D475-448A-90A3-89FCA9F06CF9 Q39920872-017CB883-9849-4F5D-A95A-E28CA8728344 Q40976667-421E3B46-469B-42C6-B2DC-489F134B3855 Q41601826-2B685199-F1A7-460D-81E2-236D3460BC2A Q41771883-7889860E-53BE-4C71-8056-6253DB6164EB Q47139877-9FFB224F-8180-421E-9BCE-D6AC0C3B4C7A Q47314399-80AFCEB6-FDE8-4777-98F5-E43A539A46D9 Q52370705-3CF64FD3-530E-4148-A701-C02DCDF17DD1

P2860

Autoantibodies in rheumatoid arthritis and their clinical significance.

http://www.wikidata.org/entity/Q34731269

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Autoantibodies in rheumatoid arthritis and their clinical significance.

@ast

Autoantibodies in rheumatoid arthritis and their clinical significance.

@en

Autoantibodies in rheumatoid arthritis and their clinical significance.

@nl

type

label

Autoantibodies in rheumatoid arthritis and their clinical significance.

@ast

Autoantibodies in rheumatoid arthritis and their clinical significance.

@en

Autoantibodies in rheumatoid arthritis and their clinical significance.

@nl

prefLabel

Autoantibodies in rheumatoid arthritis and their clinical significance.

@ast

Autoantibodies in rheumatoid arthritis and their clinical significance.

@en

Autoantibodies in rheumatoid arthritis and their clinical significance.

@nl

P1433

Q34731269-FB4166E8-EB23-4F6D-8A59-F76D535009A2

P1476

Q34731269-D55CA8A4-93AD-4FE3-9983-F8E81D9E2D85

P2093

Q34731269-BB41B5DD-3838-4261-B8D5-9568F0EC4A8C

P2860

Q34731269-07B79BF3-0111-49FC-99BC-8BEA93941D30

Q34731269-09A0A97F-08EC-4577-AE91-F1A82F9AF212

Q34731269-12204F3C-B2FA-455E-9998-4E51D76AD6EB

Q34731269-13A43D82-6F0A-4391-BD9E-BC73833FA023

Q34731269-14709C15-F036-477A-8ADF-D0D7338B3490

Q34731269-1D2D2607-DCE7-4BDE-9A47-8232140A555B

Q34731269-1DDCA725-BB53-41A4-B5DB-7C5DE842C267

Q34731269-2F18AFC6-7153-4F1C-A7C2-11788A53A63C

Q34731269-30163DC7-2A50-4E2E-8874-751F7D656BB4

Q34731269-3E34B33E-131D-493B-B5F0-346F56996CB9

P2888

Q34731269-E013DEA0-8DA2-4399-BFE8-8A0C9B23B691

P304

Q34731269-63D2C5E6-DA08-4D67-ACC9-E83C4E7AB408

P31

Q34731269-7F7641D5-F76A-4F1D-B572-7E5D45FDD879

Q34731269-9CE77453-82C4-4CC1-A35C-E3CB6441CD6F

P356

Q34731269-D565EAF3-B6A1-47BE-B3FC-ACFC2B1C9C9A

P478

Q34731269-32FF734A-CFEF-4B85-B939-0334AFDC9B8E

P50

Q34731269-CEDB4BA9-93A9-424D-B414-EFF7F5549E5F

P577

Q34731269-3C7FDC81-C449-4664-A931-FF28FD4666E2

P5875

Q34731269-8A1BDDC1-C552-4F5A-BFA3-B041C3A4B42C

P6179

Q34731269-3E8D56FA-7F20-47F1-B2CD-2BFE6C603FBA

P698

Q34731269-B1B54A37-AF6A-4CE7-B23C-B0507D93D707

P921

Q34731269-5588C043-D4C3-49B6-93C4-912FC7F40887

Q34731269-713F9F03-F923-405C-A455-D6EF64EBC17E

Q34731269-BA33A868-E9A1-4313-9666-D00433F8580D

Q34731269-BA6F4C93-7042-4B69-81D2-CE4ADEF10647

P932

Q34731269-BD0420C8-21DA-491D-9C55-3330599B9D7B

P356

P1433

Arthritis Research and Therapy

P1476

Autoantibodies in rheumatoid arthritis and their clinical significance.

@en

P2093

Günter Steiner

http://www.w3.org/2001/XMLSchema#string

P2860

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

Anti-keratin antibodies in rheumatoid arthritis

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

DEMONSTRATION OF A NEW ANTINUCLEAR FOR RHEUMATOID ARTHRITIS ANTIBODY (ANTI-RA33) THAT IS HIGHLY SPECIFIC

Proteinase 3, Wegener's autoantigen: from gene to antigen

The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis.

The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin.

From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins.

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

Autoantibodies in the diagnosis of systemic rheumatic diseases.

P2888

P304

S1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR551

http://www.w3.org/2001/XMLSchema#string

P478

4 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11268675

http://www.w3.org/2001/XMLSchema#string

P6179

1043507092

http://www.w3.org/2001/XMLSchema#string

P698

12110150

http://www.w3.org/2001/XMLSchema#string

P921

rheumatoid arthritis

P932

3238219

http://www.w3.org/2001/XMLSchema#string